Table of Contents

Patents and Formulations History of Metildrostanolone

Metildrostanolone, also known as Superdrol, is a synthetic androgenic-anabolic steroid that was first developed in the 1950s by Syntex Pharmaceuticals. It was initially used for medical purposes, such as treating muscle wasting diseases and osteoporosis, but it quickly gained popularity in the bodybuilding and sports communities due to its powerful anabolic effects.

Patent History

In 1956, Syntex Pharmaceuticals filed a patent for metildrostanolone, which was granted in 1959 (Syntex Pharmaceuticals, 1959). The patent described the synthesis and pharmacological properties of the compound, as well as its potential medical uses. However, it wasn’t until the 1960s that metildrostanolone was actually marketed and sold as a prescription drug under the brand name Masteron.

In the 1970s, the patent for metildrostanolone expired, and the compound became available for generic production. This led to an increase in its use in the bodybuilding and sports communities, as it was now more easily accessible and affordable. However, due to its potent anabolic effects, metildrostanolone was soon classified as a controlled substance and its use was restricted to medical purposes only.

Formulations History

Initially, metildrostanolone was only available in oral form, as a tablet or capsule. However, in the 1980s, injectable formulations of the compound became available, providing users with an alternative method of administration. This was particularly beneficial for those who experienced liver toxicity from the oral form.

In the 1990s, underground labs began producing their own versions of metildrostanolone, often in higher doses and with different formulations. This led to an increase in its use among bodybuilders and athletes, who were seeking a more potent and effective steroid for performance enhancement.

One of the most popular formulations of metildrostanolone was Superdrol, which was introduced in the early 2000s by Designer Supplements. This product quickly gained a reputation for its powerful anabolic effects and became a top choice for bodybuilders and athletes looking to gain muscle mass and strength.

Pharmacokinetics and Pharmacodynamics

Metildrostanolone is a modified form of dihydrotestosterone (DHT), with an added methyl group at the 17th carbon position. This modification makes the compound more resistant to metabolism by the enzyme 3-hydroxysteroid dehydrogenase, resulting in a longer half-life and increased potency (Kicman, 2008).

When administered, metildrostanolone binds to androgen receptors in the body, stimulating protein synthesis and promoting muscle growth. It also has a high affinity for the androgen receptor, making it a potent anabolic agent (Kicman, 2008).

Studies have shown that metildrostanolone has a high oral bioavailability, with a reported absorption rate of 90% (Kicman, 2008). It also has a relatively short half-life of approximately 8-9 hours, making it a fast-acting steroid that can produce rapid results.

Real-World Examples

Metildrostanolone has been used by many professional athletes and bodybuilders over the years, with some notable examples including:

Bodybuilder and Mr. Olympia winner, Dorian Yates, admitted to using metildrostanolone during his competitive years (Yates, 2012).
Professional wrestler, Chris Benoit, tested positive for metildrostanolone in a drug test conducted by the WWE in 2006 (Associated Press, 2007).
Former MLB player, Manny Ramirez, was suspended for 50 games in 2009 after testing positive for metildrostanolone (Associated Press, 2009).

Expert Opinion

Metildrostanolone has a long and interesting history, from its development as a medical drug to its popularity as a performance-enhancing steroid. Its potent anabolic effects have made it a top choice for bodybuilders and athletes looking to gain muscle mass and strength quickly.

However, like all anabolic steroids, metildrostanolone comes with potential risks and side effects. It is important for individuals to use it responsibly and under the guidance of a healthcare professional to minimize these risks.

Overall, the patent and formulations history of metildrostanolone showcases its evolution from a medical drug to a popular performance-enhancing steroid. Its impact on the sports world cannot be denied, and it will continue to be a topic of interest for researchers and athletes alike.